Egypt pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$387.9 million | 72.7% |
| 3002 Human blood | US$72.7 million | 13.6% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$59.7 million | 11.2% |
| 3003 Medicaments | US$8.3 million | 1.6% |
| 3006 Pharmaceutical goods | US$4.4 million | 0.8% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$435,000 | 0.1% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$310.9 million | 58.3% |
| 300510 Dressings, adhesive: and other articles having an adhesive layer, packed for retail sale for medical, surgical, dental or veterinary purposes | US$52.4 million | 9.8% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$52.0 million | 9.7% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$26.4 million | 4.9% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$22.1 million | 4.1% |
| 300239 Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | US$19.3 million | 3.6% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$18.9 million | 3.5% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$7.4 million | 1.4% |
| 300590 Wadding, gauze, bandages and similar articles: (excluding adhesive dressings), impregnated or coated with pharmaceutical substances, packaged for retail sale | US$7.3 million | 1.4% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$4.0 million | 0.7% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$2.7 billion | 76.2% |
| 3002 Human blood | US$586.1 million | 16.7% |
| 3003 Medicaments | US$119.0 million | 3.4% |
| 3006 Pharmaceutical goods | US$88.7 million | 2.5% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$32.7 million | 0.9% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$8.4 million | 0.2% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$1.9 billion | 54.5% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$340.4 million | 9.7% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$334.8 million | 9.6% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$111.7 million | 3.2% |
| 300239 Vaccines: for veterinary medicine, for other uses than against foot and mouth disease | US$104.2 million | 3.0% |
| 300220 Vaccines: for human medicine | US$103.7 million | 3.0% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$98.7 million | 2.8% |
| 300440 Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$69.2 million | 2.0% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$64.8 million | 1.8% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$64.7 million | 1.8% |
Shares are of Egypt's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Egypt's trade.
More Egypt products
- 27 Mineral fuels, mineral oils and products of their distillation
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 10 Cereals
- 85 Electrical machinery and equipment and parts thereof
- 72 Iron and steel
- 87 Vehicles
- 39 Plastics and articles thereof
- 71 Natural, cultured pearls
- 08 Fruit and nuts, edible
- 29 Organic chemicals
- 31 Fertilizers
- 74 Copper and articles thereof
Egypt pharmaceutical products: questions and answers
How much pharmaceutical products does Egypt export?
In 2024, Egypt exported US$533.4 million of pharmaceutical products (HS chapter 30), 1.0% of its total exports. That ranks it 50 of 213 exporting countries in the data.
What are Egypt's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$387.9 million), Human blood (3002, US$72.7 million), Wadding, gauze, bandages (dressings, adhesive plasters… (3005, US$59.7 million).
How much pharmaceutical products does Egypt import?
In 2024, Egypt imported US$3.5 billion of pharmaceutical products (HS chapter 30), 3.6% of its total imports. That ranks it 37 of 226 importing countries in the data.
What are Egypt's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$2.7 billion), Human blood (3002, US$586.1 million), Medicaments (3003, US$119.0 million).
